2nd International Congress Clinically Relevant Drug Transporters

Berlin, (PresseBox) - Recent FDA regulations and the EMA’s guideline on the investigation of drug interactions, as well as the ITC whitepaper are setting new challenges for pharmaceutical companies dealing with drug transporters and drug metabolism and pharmacokinetics (DMPK). IQPC’s International Congress Clinically Relevant Drug Transporters from 12 - 14 April, 2011 in Berlin, Germany, will bring together pharmaceutical and academic scientists to discuss the current issues affecting drug transporters research and development.

Main areas of discussions will be:

• Effective testing and modelling methodology
• In vitro-to-in vivo and preclinical-to-clinical translation of transport data
• Impact of regulatory authorities and the ITC whitepaper
• The impact of membrane transporters on drug development programmes

On 12 and 13 April, delegates will hear case studies from leading companies and institutions in the field of drug transporters such as Sanofi-Aventis Deutschland GmbH, Johnson & Johnson, Belgium, the University of Toronto, Canada and the University of Tokyo, Japan.

During the Interactive Workshop Day on 14 April, delegates can enhance their knowledge of topics such as:

• Neurovascular unit and biochemical barrier function
• Modelling of transporter driven DDI
• Model-based drug development: Incorporating population variability into mechanistic prediction of PK and modelling of PK-PD
• Species differences in drug transport and drug metabolism - do we have good enough experimental models to work with?

Further information, including the full conference program and additional content downloads, are available on www.drug-transporters.com/PR


IQPC provides business solutions around the world with tailored practical conferences, large scale events, topical seminars and in-house training programs, keeping them up-to-date with industry trends, technological developments and the regulatory landscape. IQPC produces more than 1,500 events annually around the world, and continues to grow. IQPC has offices in major cities across six continents including: Bengaluru, Berlin, Dubai, London, New York, Sao Paulo, Singapore and Sydney. IQPC leverages a global research base of best practices to produce an unrivalled portfolio of conferences.

Press releases you might also be interested in

Weitere Informationen zum Thema "Medizintechnik":

„AppliedAI“-Initiative will KI in Deutschland voranbringen

Je­des Jahr ein deut­sches Start-up aus dem Um­feld der Künst­li­chen In­tel­li­genz (KI) in die in­ter­na­tio­na­len Top-100-Lis­ten brin­gen – so lau­tet ei­nes der Zie­le, das sich die In­i­tia­ti­ve „Ap­p­lie­dAI“ auf die Fah­ne ge­schrie­ben hat. Un­ter der Äg­i­de der Baye­ri­schen Staats­re­gie­rung und mit Un­ter­stüt­zung der Tech­ni­schen Uni­ver­si­tät Mün­chen ko­ope­rie­ren 26 For­schung­s­ein­rich­tun­gen und Kon­zer­ne.


Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.